• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体介导的NRDP1在前列腺癌细胞中的核转运与患者预后较差相关。

Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes.

作者信息

Steele Thomas, Sam Anhao, Evans Shawna, Browning Elizabeth, Krig Sheryl, Macias Katelyn, Konda Adarsh, Siddiqui Salma, Durbin-Johnson Blythe, Ghosh Paramita, Vinall Ruth

机构信息

Department of Pharmaceutical & Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, CA 95757, USA.

Department of Urological Surgery, School of Medicine, University of California Davis, 4860 Y Street, Sacramento, CA 95817, USA.

出版信息

Cancers (Basel). 2021 Sep 2;13(17):4425. doi: 10.3390/cancers13174425.

DOI:10.3390/cancers13174425
PMID:34503235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8430998/
Abstract

To our knowledge, our group is the first to demonstrate that NRDP1 is located in the nucleus as well as the cytoplasm of CaP cells. Subcellular fractionation, immunohistochemistry, and immunofluorescence analysis combined with confocal microscopy were used to validate this finding. Subcellular fractionation followed by western blot analysis revealed a strong association between AR and NRDP1 localization when AR expression and/or cellular localization was manipulated via treatment with R1881, AR-specific siRNA, or enzalutamide. Transfection of LNCaP with various NRDP1 and AR constructs followed by immunoprecipitation confirmed binding of NRDP1 to AR is possible and determined that binding requires the hinge region of AR. Co-transfection with NRDP1 constructs and HA-ubiquitin followed by subcellular fractionation confirmed that nuclear NRDP1 retains its ubiquitin ligase activity. We also show that increased nuclear NRDP1 is associated with PSA recurrence in CaP patients (n = 162, odds ratio; 1.238, = 0.007) and that higher levels of nuclear NRDP1 are found in castration resistant cell lines (CWR22Rv1 and PC3) compared to androgen sensitive cell lines (LNCaP and MDA-PCa-3B). The combined data indicate that NRDP1 plays a role in mediating CaP progression and supports further investigation of both the mechanism by which nuclear transport occurs and the identification of specific nuclear targets.

摘要

据我们所知,我们的研究小组是首个证明NRDP1定位于前列腺癌细胞的细胞核和细胞质中的团队。采用亚细胞分级分离、免疫组织化学和免疫荧光分析并结合共聚焦显微镜来验证这一发现。通过用R1881、AR特异性小干扰RNA(siRNA)或恩杂鲁胺处理来操控AR表达和/或细胞定位后,进行亚细胞分级分离,随后的蛋白质免疫印迹分析显示AR与NRDP1定位之间存在强关联。用各种NRDP1和AR构建体转染LNCaP细胞,随后进行免疫沉淀,证实NRDP1与AR之间可能存在结合,并确定这种结合需要AR的铰链区。用NRDP1构建体和HA-泛素共转染,随后进行亚细胞分级分离,证实细胞核中的NRDP1保留其泛素连接酶活性。我们还表明,细胞核中NRDP1增加与前列腺癌患者(n = 162,比值比;1.238,P = 0.007)的PSA复发相关,并且与雄激素敏感细胞系(LNCaP和MDA-PCa-3B)相比,在去势抵抗细胞系(CWR22Rv1和PC3)中发现细胞核NRDP1水平更高。综合数据表明,NRDP1在介导前列腺癌进展中起作用,并支持对核转运发生机制以及特定核靶点鉴定的进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/8d81d07cf327/cancers-13-04425-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/3f1053f54fa8/cancers-13-04425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/8b5994d871bd/cancers-13-04425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/305a94de9a73/cancers-13-04425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/6a757fd56c4c/cancers-13-04425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/babd57849748/cancers-13-04425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/d8bfeb20a6d4/cancers-13-04425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/9d18da49bf7f/cancers-13-04425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/8d81d07cf327/cancers-13-04425-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/3f1053f54fa8/cancers-13-04425-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/8b5994d871bd/cancers-13-04425-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/305a94de9a73/cancers-13-04425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/6a757fd56c4c/cancers-13-04425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/babd57849748/cancers-13-04425-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/d8bfeb20a6d4/cancers-13-04425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/9d18da49bf7f/cancers-13-04425-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de53/8430998/8d81d07cf327/cancers-13-04425-g008.jpg

相似文献

1
Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes.雄激素受体介导的NRDP1在前列腺癌细胞中的核转运与患者预后较差相关。
Cancers (Basel). 2021 Sep 2;13(17):4425. doi: 10.3390/cancers13174425.
2
Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer.在前列腺癌中,雄激素受体对Nrdp1的转录受细胞核内细丝蛋白A调控。
Endocr Relat Cancer. 2015 Jun;22(3):369-86. doi: 10.1530/ERC-15-0021. Epub 2015 Mar 10.
3
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.Nrdp1 通过雄激素受体调节雄激素依赖性但非去势抵抗性前列腺癌细胞中 ErbB3 的表达。
Cancer Res. 2010 Jul 15;70(14):5994-6003. doi: 10.1158/0008-5472.CAN-09-4440. Epub 2010 Jun 29.
4
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.在人类前列腺癌模型中,雄激素对恶性生长的反应性与前列腺特异性分化标志物前列腺特异性抗原(PSA)、人激肽释放酶2(hK2)和前列腺特异性膜抗原(PSMA)表达之间的解离。
Prostate. 2003 Mar 1;54(4):249-57. doi: 10.1002/pros.10199.
5
A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant AR nuclear import and function.一种新型雄激素受体拮抗剂 JJ-450 抑制恩杂鲁胺耐药突变型 AR 核内输入和功能。
Prostate. 2020 Mar;80(4):319-328. doi: 10.1002/pros.23945. Epub 2019 Dec 23.
6
Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.核孔蛋白62和钙/钙调蛋白依赖性蛋白激酶激酶2调节去势抵抗性前列腺癌细胞中的雄激素受体活性。
Prostate. 2016 Feb 15;76(3):294-306. doi: 10.1002/pros.23121. Epub 2015 Nov 10.
7
Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.碱性螺旋-环-螺旋(bHLH)转录因子3(TCF3,E2A)在前列腺癌细胞中受雄激素调控。
Am J Cancer Res. 2015 Oct 15;5(11):3407-21. eCollection 2015.
8
Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells.雄激素受体活性受核基质定位和雄激素治疗的 LNCaP 细胞中异质核核糖核蛋白 K 的磷酸化状态的影响。
PLoS One. 2013 Nov 13;8(11):e79212. doi: 10.1371/journal.pone.0079212. eCollection 2013.
9
Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.恩杂鲁胺治疗的骨转移性去势抵抗性前列腺癌的分子特征
Eur Urol. 2015 Jan;67(1):53-60. doi: 10.1016/j.eururo.2014.05.005. Epub 2014 May 29.
10
The androgen receptor and prostate cancer invasion.雄激素受体与前列腺癌侵袭
Mol Cell Endocrinol. 2006 Feb 26;246(1-2):157-62. doi: 10.1016/j.mce.2005.11.006. Epub 2005 Dec 20.

引用本文的文献

1
Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors.分泌松弛素-2的嵌合抗原受体T细胞在富含基质的异种移植肿瘤中表现出增强的疗效。
Front Immunol. 2025 Jul 1;16:1506204. doi: 10.3389/fimmu.2025.1506204. eCollection 2025.

本文引用的文献

1
The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics.泛素特异性肽酶(USP8)的致癌作用及其作为癌症治疗靶点的信号通路。
Arch Biochem Biophys. 2021 Apr 15;701:108811. doi: 10.1016/j.abb.2021.108811. Epub 2021 Feb 16.
2
Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer.雄激素受体核定位在去势抵抗性前列腺癌中的调控和靶向作用。
J Clin Invest. 2021 Feb 15;131(4). doi: 10.1172/JCI141335.
3
Knockdown of USP8 Inhibits the Growth of Lung Cancer Cells.
USP8基因敲低抑制肺癌细胞生长。
Cancer Manag Res. 2020 Dec 2;12:12415-12422. doi: 10.2147/IJN.S259191. eCollection 2020.
4
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy.前列腺癌中的雄激素受体:结构、配体及剪接变体对治疗的影响
Biomedicines. 2020 Oct 15;8(10):422. doi: 10.3390/biomedicines8100422.
5
Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer.前列腺癌中雄激素依赖性和非依赖性雄激素受体活性的翻译后调控
Asian J Urol. 2020 Jul;7(3):203-218. doi: 10.1016/j.ajur.2019.11.001. Epub 2019 Nov 20.
6
Androgen receptor co-regulation in prostate cancer.前列腺癌中的雄激素受体共调节
Asian J Urol. 2020 Jul;7(3):219-232. doi: 10.1016/j.ajur.2019.09.005. Epub 2019 Oct 4.
7
Regulating tumor suppressor genes: post-translational modifications.调控肿瘤抑制基因:翻译后修饰。
Signal Transduct Target Ther. 2020 Jun 10;5(1):90. doi: 10.1038/s41392-020-0196-9.
8
The role of ubiquitination in tumorigenesis and targeted drug discovery.泛素化在肿瘤发生和靶向药物发现中的作用。
Signal Transduct Target Ther. 2020 Feb 29;5(1):11. doi: 10.1038/s41392-020-0107-0.
9
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
10
Nrdp1 increases neuron apoptosis via downregulation of Bruce following intracerebral haemorrhage.脑出血后,Nrdp1通过下调Bruce增加神经元凋亡。
J Inflamm (Lond). 2019 Dec 9;16:24. doi: 10.1186/s12950-019-0229-8. eCollection 2019.